Robert F. Kennedy Jr's nomination to lead the Department of Health and Human Services is poised to get the same kind of scrutiny some of Donald Trump's Cabinet nominees have been receiving starting next week.
According to a report from the Washington Post, Kennedy has benefited with the press focusing on embattled Fox News personality Pete Hegseth, ex-Rep. Tulsi Gabbard's nomination to be the Director of National Intelligence, and Kash Patel to head up the FBI –– but that is about to end.
The report notes that Kennedy, who has a colorful history of antics and opinions on health issues, has scheduled meetings with 23 senators next week where he likely will face a grilling on a multitude of topics near and dear to lawmakers hearts.
ALSO READ: Agenda 47: Alarm sounded about Trump’s dystopian plans for his second term
According to the Post, "when the spotlight turns to RFK, one GOP senator predicted the blowback could be intense," with the report noting there is pushback against his nomination, not just over his previous statements about health and science, but other positions he has taken over the years.
"Senators could receive pressure from multiple directions, including from antiabortion activists who don’t like his pro-choice posture and from the moneyed pharmaceutical industry, which is fundamentally and financially opposed to Kennedy’s position on vaccines and pharmaceuticals," the Post is reporting while also noting that Donald Trump has dialed back putting pressure on Republicans about his nominees after Rep. Matt Gaetz (R-FL) withdrew his name to be attorney general he was unable to make his case with reportedly a substantial number of Republican senators.
You can read more here.
